NeuroVive Pharmaceutical AB organizacji ROCE
Jaka jest wartość ROCE organizacji NeuroVive Pharmaceutical AB?
Wartość ROCE organizacji NeuroVive Pharmaceutical AB to -66.00%
Jaka jest definicja ROCE?
Zwrot z zaangażowanego kapitału Return on capital employed (ROCE) to wskaźnik finansowy, który mierzy zyskowność przedsiębiorstwa i efektywność, z jaką wykorzystywany jest jego kapitał.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE firm w Miscellaneous sektor na LSE w porównaniu do NeuroVive Pharmaceutical AB
Czym się zajmuję organizacja NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Firmy z roce podobne do NeuroVive Pharmaceutical AB
- Wartość ROCE organizacji Revance Therapeutics Inc to -66.25%
- Wartość ROCE organizacji Castlecap Capital to -66.21%
- Wartość ROCE organizacji CASI Pharmaceuticals Inc to -66.16%
- Wartość ROCE organizacji Argent Minerals to -66.09%
- Wartość ROCE organizacji 17 Education & Technology to -66.03%
- Wartość ROCE organizacji Bed, Bath & Beyond to -66.01%
- Wartość ROCE organizacji NeuroVive Pharmaceutical AB to -66.00%
- Wartość ROCE organizacji Aurum Resources Ltd to -65.87%
- Wartość ROCE organizacji Allot Ltd to -65.75%
- Wartość ROCE organizacji Eledon Pharmaceuticals to -65.68%
- Wartość ROCE organizacji Arrowhead Pharmaceuticals to -65.68%
- Wartość ROCE organizacji Stereotaxis to -65.63%
- Wartość ROCE organizacji UroGen Pharma to -65.59%